Early insulin therapy has been associated with hyperphagia, weight gain, and lipogenesis, which may exacerbate insulin resistance and metabolic changes in T2DM, potentially necessitating intensified treatment (Anderwald et al., 2002; McFarlane, 2009; Rachdaoui, 2020). Here, INS is linked to type 2 diabetes mellitus.